Faulkner Eric
SEC insider (Form 3/4/5 filer). CIK 0002113815. Chief Technology Officer at CNS Pharmaceuticals, Inc. (CNSP). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 2, 2026. Located in HOUSTON, TX.
Companies Faulkner Eric has filed insider reports for
- CNS Pharmaceuticals, Inc. (CNSP): Officer, Chief Technology Officer
Faulkner Eric
CIK: 0002113815
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNSP
CNS Pharmaceuticals, Inc.
Officer